텔콘RF제약

200230KOSDAQView the 제약 sectorTheme Bio & healthcare

2,190KRWMarket close of 10/20 (Tue)

Flat 0.00%0KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)2,145KRWDown -2.05%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open: 2,170
High: 2,230
Low: 2,160
Day range: Day range low 2,160 high 2,230, open 2,170, close 2,190, previous close 2,190
Volume: 0×10K shares
: 8.21 million KRW 0.20× the 20-session average

Market close of 10/20 (Tue)

Usual range

Nothing unusual in the 4 checked items

Free · no sign-inSource from 2021-05-17

Points to check

Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
Daily moveusual range0.00%0.00%, 0.0× the usual (20-session average ±2.15%)
That day 0.00% · usual ±2.15% · large-move threshold ±4.3%

The other 3 are within the usual range

Trading value0.2×usual range
EarningsOperating income, 8 quartersOperating income, 8 quarters
Data date10/20 (Tue)Market close

See the full check report

Key figures

: 20.8B KRW
: Not computed — loss-making, or the four quarters are incomplete
: 0.21×
: 9,482,269 shares
Trading value ratio: 0.20× the 20-session average0.2×

Financials filed 2026-05-15 · KRX·DART

Usual range

Nothing unusual in the 4 checked items

Recent filingsnot verifiedOutside filing data coverage, so not verified
Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
Daily moveusual range0.00% on the reference date, placed against the usual ±2.15% band0.0×
Trading valueusual range0.20× the 20-session average0.2×
Earningsusual rangeQuarterly operating income bars (6); the four dark bars make up the sum795.00 million KRW
Data dateusual rangeMarket close data of 2026-10-20

Quarterly results · Q1 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected

Revenue9.7B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
-2.8%
vs. prior quarter
-27.2%
Operating income-1.4B KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
Still a loss
vs. prior quarter
Turned to loss
Operating margin-14.7%Operating margin bars for the last 8 quarters; the dark bar is this quarter
vs. year ago
+0.3 pp
vs. prior quarter
-34.4 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-05-15

2021Q1 -1.6B KRW2026Q1 -1.4B KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock	20D	Change	Trading value
셀트리온	Close over the last 20 sessions +11.4%	Down -0.40%	139.2B KRW
삼성바이오로직스	Close over the last 20 sessions -1.3%	Down -2.52%	129.9B KRW
삼익제약	Close over the last 20 sessions -20.4%	Up +2.77%	76.0B KRW
녹십자엠에스	Close over the last 20 sessions +30.5%	Up +6.67%	55.6B KRW
유한양행	Close over the last 20 sessions +11.5%	Down -1.37%	41.6B KRW

Schedule

Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.